Legal Representation
Attorney
G. MATHEW LOMBARD
USPTO Deadlines
Application History
26 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 4, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Dec 4, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| May 5, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 3, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 3, 2017 | EXT2 | S | SOU EXTENSION 2 FILED |
| May 3, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Feb 23, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 22, 2017 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Feb 22, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Feb 6, 2017 | PROA | I | TEAS PETITION TO REVIVE RECEIVED |
| Feb 6, 2017 | PETG | O | PETITION TO REVIVE-GRANTED |
| Feb 6, 2017 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Feb 6, 2017 | NREV | E | NOTICE OF REVIVAL - E-MAILED |
| Dec 5, 2016 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Dec 5, 2016 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Nov 3, 2016 | EXT1 | S | SOU EXTENSION 1 FILED |
| May 3, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Mar 8, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 8, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Feb 24, 2016 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Feb 17, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jan 28, 2016 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 28, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 14, 2015 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Oct 13, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 10, 2015 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Gel injected between prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical devices, namely, synthetic implants in the nature of a gel injected between prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the wording "BARRIGEL" written in the color blue to the right of two concentric circle, the outer circle appears in the color blue and the inner circle in the color orange, outlined by a transparent circle, and the color white appearing in the mark is not part of the mark and represents outlining or a transparent area.
Color Claim
The color(s) blue and orange is/are claimed as a feature of the mark.
Classification
International Classes
005
010
USPTO Documents
Loading USPTO documents...